PHILADELPHIA — Members of the LGBT community have a unique set of health needs, interests and risks. They are statistically more likely to be at risk of depression, STDs, cancer, tobacco, alcohol and other drug use than their heterosexual counterparts. But, LGBT individuals face many barriers to high quality patient-centered care, including decreased access to healthcare, lack of awareness and insensitivity to their unique health needs, and
inequitable policies and practices.
The Penn Medicine Program for LGBT Health, established in 2013 and a key initiative of the Office of Inclusion and Diversity, aims to support the health and well being of LGBT populations by becoming a local and national leader in LGBT patient care, education, research, and advocacy.
The initative’s first educational program will bring together national and local leaders in LGBT health who will address the Affordable Care Act’s impact on LGBT community, LGBT research and education, and LGBT health and patient care in Philadelphia. The program is collaboration with Penn’s Center for Public Health Initiatives and the Leonard Davis Institute of Health Economics.
WHEN:
Tuesday, April 1, 2014, 4 PM to 6:00 PM
WHERE:
John Morgan Building, Reunion Auditorium
3620 Hamilton Walk
Philadelphia, PA 1910
WHO:
Baligh Yehia, MD MPP, MSHP
Assistant Professor of Medicine,
Director, Penn Medicine Program for LGBT Health
Kellan Baker
Associate Director, LGBT Research and Communications
Center for American Progress
Nurit Shein
Executive Director, Mazzoni Center
Mitchell R. Lunn
Founder and Investigator, LGBT Medical Education Research Group
Stanford University, School of Medicine
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.